semaj83/ctmatch_classification huggingface dataset:
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Influenza Ages Eligible for Study Years Years Genders Eligible for Study: Both Accepts Healthy Volunteers Healthy adult volunteers (women must be of non child-bearing potential) Provided written informed consent  No significant concomitant illness No allergy to gold No immunosuppression due to disease or treatment No previous flu vaccination in 2005 or 2006
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Healthy Subjects Men or women aged 18 to 50 years Healthy as determined by the investigator  History or active presence of clinically important medical disease History of drug or alcohol abuse
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.5-4.917,  Respiratory Infections Diarrhea Malnutrition Age 6-59 months 2. Either sex 3. Severe malnutrition as defined by the presence of any of the followings Bipedal oedema Weight (measured after correction of dehydration) for height Z score <-3 of the National Center for Health Statistics (NCHS) reference Written informed consent of respective parents/ guardians for participation of the children in the study. 4. Children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours  Failure to obtain consent 2. Received a dose of vitamin A within the last three months 3. History of night blindness or eye signs of vitamin A deficiency 4. Measles or history of measles within last 8 weeks [56] 5. Clinical suspicion of TB (evening rise of temperature, loss of appetite, gradual loss of weight, cough, night sweating) after applying modified Kenneth Jones [57], shock other than due to hypovolaemia or hypoglycaemia, congestive cardiac failure, severe sepsis (hypothermia, tachycardia, tachypnea, hypotension) [58], and seizure disorders 6. Trisomy-21 7. Cerebral palsy 8. Any other known chronic disease (e.g. hepatic, renal or congenital disorder) or malignant condition
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-30.0,  Breast Cancer Obesity Healthy women Self-reported menstrual cycle length of 25-35 days within the past 2 months Nonsmoker Sedentary (exercise < 3 times weekly within the past 6 months) Intact ovaries and uterus No history of gynecological problems (e.g., fibroids, endometriosis, polycystic ovary syndrome) Female Premenopausal Body mass index 18.5 to 40 Stable weight (no changes ≥ 10% within the past year)  No pregnancy or breast feeding within the past 6 months No plans to become pregnant during study treatment No cancer within the past 5 years except for nonmelanoma skin cancers No medical condition that would prohibit participation in a vigorous program of weight-bearing aerobic exercise including, but not limited to, any of the following Fibromyalgia Chronic fatigue syndrome Metabolic disorders Recent cardiovascular event Orthopedic limitations Psychiatric disorders requiring antipsychotic drugs
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Influenza Hospital employees, staff physicians, residents, rn's, lpn's  non patient care hospital employees
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-45.0,  Healthy Japanese healthy male subjects age 20 to 45 years of age, and in good health At screening and baseline, the subjects must be in good health as determined by past medical history, physical examination, electrocardiogram, laboratory tests and urinalysis Body mass index within the range of 17 to 25 kg/m2 and weigh at least 50 kg  Smokers (use of tobacco products in the previous 3 months). Urine cotinine levels will be measured during screening for all subjects. Smokers will be defined as any subject who reports tobacco use or has a urine cotinine 'high' level in checking by NicCheck® I Use of any prescription drugs within 4 weeks prior dosing, or over-the-counter medication (vitamins, herbal supplements, dietary supplements) within 2 weeks prior to dosing. Acetaminophen is acceptable Participation in any clinical investigation within 4 months prior to study start Donation or loss of 400 mL or more of blood within 3 months; donation or loss of 200 mL or more of blood within 1 month; or donation of component blood within 2 weeks prior to study start Subjects considered unsuitable for participation in the study within 2 weeks prior to dosing A past medical history of clinically significant abnormality detected during electrocardiogram (ECG) examination or an evident family history (grandparents, parents and siblings) of a ECG abnormality (i.e. prolonged QT-interval syndrome) History of fainting, hypotension when standing up, arrhythmia History of acute or chronic bronchospastic disease (including asthma and chronic obstructive pulmonary disease, treated or not treated) History of clinically significant drug allergy, history or presence of atopic allergy (asthma, urticaria, eczematous dermatitis) unless inactive seasonal allergy, or history of food allergy. A known hypersensitivity to the study drug or drugs similar to the study drug Any surgical or medical condition which might significantly alter the absorption, distribution, metabolism or excretion of drugs or which may jeopardize the subject in case of participation in the study
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-30.0,  Healthy Age equal to or greater than18 years of age 2. No history of allergy or adverse reaction to any NSAID 3. No use of any NSAID in past 2 weeks 4. No history of peptic ulcer disease (PUD), gastroesophageal disease (GERD), or gastritis 5. No major medical history including but not limited to diabetes, hypertension, asthma, kidney disease and coronary artery disease 6. Currently not taking any medication including oral contraceptives  Age < 18 years of age 2. History of allergy or adverse reaction to any NSAID 3. Use of any NSAID in past 2 weeks 4. History of a bleeding disorder 5. History of PUD, GERD, or gastritis 6. Pregnant 7. A medical history of diabetes, hypertension, asthma, kidney disease or coronary artery disease 8. Taking any medication including oral contraceptives
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 10.0-999.0,  Conjunctivitis, Allergic At least 10 years of age & either sex, any race Willing and able to follow all instructions and attend all study visits Positive history of ocular allergies  Have planned surgery during trial period Female currently pregnant, planning a pregnancy, or lactating
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Asthma baseline FEV1 > or = 65% predicted positive methacholine challenge (i.e. methacholine PC20 < or = 16mg/ml positive allergen challenge  negative skin prick test lung condition/disease other than asthma currently use montelukast and/or desloratadine
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 1.0-999.0,  Influenza Participants should be informed and assent to participate in this study. For children, informed consent should be provided by their parents or legal guardians. Children aged from 10 years old to 18 years old will be asked to assent Adults or children older than 1 year old Satisfying above definition of cases and controls  Infants younger than 12 months For any cases or controls who need proxy, they should be excluded under below situations: 1. Proxy can not provide sufficient information for this study, or 2. Proxy refuses to participate in this study, or 3. No suitable proxy can be found
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Influenza Influenza Vaccines Subjects who the investigator believes that they can and will comply with the requirements of the protocol should be enrolled in the study A male or female between, and including, 18 and 60 years of age at the time of the first vaccination Written informed consent obtained from the subject Healthy subjects as established by medical history and clinical examination before entering into the study If the subject is female, she must be of non-childbearing potential; or, if of childbearing potential, she must be abstinent or have used adequate contraceptive precautions for 30 days prior to first vaccination, have a negative pregnancy test and must agree to continue such precautions for two months after completion of the vaccination series  Administration of licensed vaccines within 2 weeks (for inactivated vaccines) or 4 weeks (for live vaccines) prior to enrolment in this study History of vaccination with investigational influenza pandemic vaccine History of administration of an experimental/licensed vaccine Planned administration of a vaccine not foreseen by the study protocol during the following periods: from Day 0 up to Day 51; from 2 weeks (for inactivated vaccines) or 4 weeks (for live vaccines) prior to Month 6 and Month 12; from Month 6 up to Month 6 + 30 days; from Month 12 up to Month 12 + 30 days Chronic administration (defined as more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to the first administration of the candidate vaccines Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination History of hypersensitivity to vaccines History of allergic disease or reactions likely to be exacerbated by any component of the vaccine History of chronic alcohol consumption and/or drug abuse Acute clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality, as determined by physical examination or laboratory screening tests
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Influenza Influenza Vaccines Subjects who the investigator believes that they can and will comply with the requirements of the protocol A male or female between, and including, 18 and 60 years of age at the time of the first vaccination Written informed consent obtained from the subject Healthy subjects as established by medical history and clinical examination before entering into the study If the subject is female, she must be of non-childbearing potential; or, if of childbearing potential, she must practice adequate contraception for 30 days prior to vaccination, have a negative pregnancy test and continue such precautions for two months after completion of the vaccination series  Administration of any licensed vaccines within 2 weeks (for inactivated vaccines) or 4 weeks (for live vaccines) prior to enrolment in this study Planned administration of a vaccine not foreseen by the study protocol during the following periods: from Day 0 up to Day 51, 2 weeks (for inactivated vaccines) or 4 weeks (for live vaccines) prior to Month 6; from Month 6 up to Month 6 + 30 days (or Month 6 + 51 days for the control groups) Previous vaccination with a pandemic candidate vaccine or a vaccine containing the same adjuvant as the study vaccine Previous proven contact with H5N1 wild type virus (i.e. contact with an individual with laboratory-confirmed H5N1 infection, or contact with an animal (e.g. poultry) which died as a result of H5N1 infection) Chronic administration (defined as more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to the first administration of the candidate vaccines Any confirmed or suspected immunosuppressive or immunodeficient condition, or autoimmune diseases such as Guillain Barre Syndrome, based on medical history and physical examination (no laboratory testing required) History of hypersensitivity to vaccines History of allergic disease or reactions likely to be exacerbated by any component of the vaccine History of chronic alcohol consumption and/or drug abuse Acute clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality, as determined by physical examination or laboratory screening tests
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Recurrent Lymphoepithelioma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Nasopharynx Stage IV Lymphoepithelioma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Histologically or cytologically confirmed nasopharyngeal carcinoma, meeting the following World Health Organization (WHO) type II-III disease Stage IV or recurrent disease Must have failed at least 1 prior line of chemotherapy for metastatic or recurrent disease Measurable disease, defined as >= 1 unidimensionally measurable lesion >= 20 mm by conventional techniques OR >= 10 mm by spiral CT scan No known brain metastases Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2 or Karnofsky PS 70-100% Life expectancy > 3 months WBC >= 3,000/mm³ Absolute neutrophil count >= 1,500/mm³
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Von Willebrand's Disorder Healthy Must be female Aged 18 to 50 years, with regular menstrual cycles Healthy volunteers and women with von Willebrand's disorder are both being recruited  Pregnancy Use of hormonal therapy including birth control pills Use of hemostatic agents such as DDAVP or anti-platelet agents
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-70.0,  Primary Operable Breast Cancer Women that are scheduled to undergo surgery of a single, stage I-III, invasive ductal or lobular carcinoma tumor with curative intent No evidence of metastatic disease prior to surgery. Minimal workup would chest XR, abdominal ultrasound and bone scan Age between 20 and 70 year old ASA score of 1-2 The patient is able to understand the study objectives and procedures, able to comply with the protocol, and is capable to sign an informed consent  Patients with metastatic disease, known prior to surgery Patients in whom surgical resection is planned without curative intent Patients who have undergone neoadjuvant treatment Patients with renal failure, measured by creatinine level >1.5 Patients with significant heart failure (NYHA functional class 3 or higher) Patients with significant liver failure (known cirrhosis, Bilirubin level>2) Patients suffering from asthma Patients with known allergy to one or more of the study medications Patients with known allergy to any medication from the non-steroidal anti-inflammatory drug group Patients with diabetes mellitus (type 1 or 2)